Skip to content
Clinical Trials – home

Renal impairment Treatment

1 / 4 trials open to patients4 countries

In short

Renal impairment, also known as chronic kidney disease, affects millions of people worldwide and requires careful management to slow its progression and maintain quality of life. Understanding the available treatment options, from medications that protect remaining kidney function to advanced therapies being tested in clinical trials, can help patients and their families navigate this challenging condition with greater confidence and hope.

Key points

  • Early detection through regular blood and urine tests is crucial since kidney disease usually has no symptoms in early stages[8]
  • Controlling blood pressure and blood sugar can significantly slow kidney damage progression[19]
  • ACE inhibitors and ARBs not only lower blood pressure but also provide special protection to your kidneys[13]
  • SGLT2 inhibitors were originally diabetes drugs but researchers discovered they also protect kidney function[13]
  • Most people with chronic kidney disease will not progress to kidney failure if they receive proper treatment[7]
  • Home-based dialysis options offer more flexibility for work, travel, and daily activities compared to hospital-based treatments
  • Clinical trials are testing new medications that target inflammation, scarring, and other mechanisms of kidney damage
  • Lifestyle changes like limiting salt, exercising regularly, and quitting smoking are as important as medications in managing kidney disease[23]

How Treatment Can Help Manage Kidney Function

When your kidneys begin to lose their ability to filter blood properly, the main goals of treatment focus on slowing down the damage, managing symptoms, and preventing complications that can affect your heart, bones, and overall health. Renal impairment means your kidneys aren't working as well as they should, but with the right approach, many people can maintain a good quality of life for years.

The treatment you receive depends heavily on how advanced your kidney disease has become. Doctors measure kidney function using a blood test called estimated glomerular filtration rate (eGFR), which tells them how well your kidneys are filtering waste. A normal eGFR is above 90, while readings below 15 indicate very severe kidney damage. Your treatment plan will also consider other factors such as your age, other health conditions like diabetes or high blood pressure, and how rapidly your kidney function is declining.

There are well-established treatments that doctors have used successfully for many years, approved by major medical organizations and based on solid evidence. At the same time, researchers around the world are testing new medications and approaches in clinical trials, searching for better ways to protect kidneys and improve outcomes for patients. Some people with early-stage disease may need only lifestyle changes and blood pressure medication, while those with more advanced kidney failure may require dialysis or transplantation.

Standard Treatments That Protect Your Kidneys

The foundation of treating renal impairment involves controlling the underlying conditions that damage your kidneys. High blood pressure is one of the most important factors to manage. Doctors aim to keep your blood pressure below 140/90 mmHg, or even lower if you also have diabetes. Several types of blood pressure medications are used, but certain ones offer special protection for your kidneys beyond just lowering pressure.

Angiotensin-converting enzyme inhibitors (ACE inhibitors) are medications that work by blocking a hormone system that can damage your kidneys over time. Common examples include ramipril, enalapril, and lisinopril. These medications help relax blood vessels and reduce the strain on your kidneys. If you develop a persistent dry cough from an ACE inhibitor, which is a common side effect, your doctor may switch you to a similar type of medication called an angiotensin-II receptor blocker (ARB). Both types of medication are particularly important if you have protein in your urine, a sign that your kidneys are being damaged.

If you have diabetes along with kidney disease, keeping your blood sugar under control is crucial. Your doctor will likely aim for a hemoglobin A1C level below 7 percent. This requires careful management of diabetes medications, which may include insulin, metformin, or newer drugs. Controlling blood sugar helps slow the damage to the tiny blood vessels in your kidneys.

For people with diabetes or a high level of albumin (a type of protein) in their urine, doctors may prescribe SGLT2 inhibitors such as dapagliflozin. These medications were originally developed to lower blood sugar, but researchers discovered they also protect the kidneys by reducing the workload on kidney cells. They help your body get rid of excess sugar through urine. Some patients may also receive a medication called finerenone, which blocks certain hormones that can damage kidneys.

Managing cholesterol is another important part of treatment. People with kidney disease have a higher risk of heart attacks and strokes, partly because kidney problems and heart problems often share the same causes. Statins such as atorvastatin and simvastatin are medications that lower cholesterol levels in your blood. Side effects can include headaches, upset stomach, constipation or diarrhea, and muscle or joint pain.

As kidney disease progresses, waste products and minerals can build up in your blood. High potassium levels (hyperkalemia) can cause muscle weakness and dangerous heart rhythm problems. If diet changes aren't enough, doctors may prescribe sodium zirconium cyclosilicate, a medication that helps your body eliminate excess potassium through the digestive system. This medication is used in emergency situations or for people whose high potassium doesn't improve with other measures.

When kidneys fail to work properly, they can't activate vitamin D, which is essential for healthy bones. They also struggle to control phosphorus levels. Many patients need to take vitamin D supplements and medications called phosphate binders, which prevent the absorption of phosphorus from food. High phosphorus can weaken bones and damage blood vessels.

Anemia, or low red blood cell count, is common in kidney disease because damaged kidneys produce less of a hormone called erythropoietin that stimulates red blood cell production. Doctors may prescribe medications that replace this hormone, along with iron supplements, to help your body make more red blood cells and reduce fatigue.

Treatment duration varies significantly depending on your situation. If you're in the early stages of kidney disease, you may take blood pressure and cholesterol medications for the rest of your life to prevent further damage. Medications to control diabetes are also typically lifelong. Your doctor will monitor your kidney function regularly with blood tests to see how well the treatment is working and whether adjustments are needed.

For people who progress to stage 5 kidney disease, also called end-stage kidney disease, the kidneys can no longer sustain life on their own. At this point, you'll need either dialysis or a kidney transplant to survive. Dialysis is a process that uses a machine or special fluid in your abdomen to clean your blood when your kidneys can't. There are two main types: hemodialysis, which cleans blood through a machine typically three times per week at a dialysis center or at home, and peritoneal dialysis, where fluid is placed into your abdomen to absorb waste, then drained.

A kidney transplant involves surgically placing a healthy kidney from a deceased or living donor into your body. The new kidney takes over the work of your failed kidneys. Transplants can come from living donors (often family members or friends) or deceased donors. After a transplant, you must take immunosuppressant medications for the rest of your life to prevent your body from rejecting the new kidney.

Promising Therapies Being Tested in Research Studies

Scientists around the world are actively searching for new ways to treat kidney disease and slow its progression. Clinical trials test experimental medications and approaches to see if they're safe and effective before they become widely available. These studies happen in phases: Phase I tests safety in a small group of people, Phase II examines whether the treatment works and continues safety testing in more people, and Phase III compares the new treatment to current standard treatments in large groups of patients.

One area of intense research focuses on medications that target inflammation and scarring in the kidneys. When kidneys are damaged by diabetes, high blood pressure, or other diseases, they develop fibrosis, which is the buildup of scar tissue that gradually destroys normal kidney function. Researchers are testing drugs that might slow or even reverse this scarring process by interfering with the cellular signals that cause fibrosis to develop.

Another promising direction involves medications that protect the kidney's filtering units, called glomeruli. Some experimental drugs work by reducing inflammation in these tiny structures or by protecting the cells that line blood vessels in the kidneys. By preserving the health of these filtering units, researchers hope to maintain kidney function for longer periods.

Newer classes of medications are being evaluated in clinical trials specifically for their kidney-protective effects. Some studies are examining whether certain anti-inflammatory drugs, immune system modulators, or medications that affect how kidneys handle salt and water can provide additional benefits beyond current treatments. These trials often measure outcomes like the rate of decline in eGFR, levels of protein in urine, and how long patients can delay the need for dialysis.

Gene therapy approaches are also being explored for certain inherited kidney diseases. These experimental treatments aim to correct genetic defects that cause progressive kidney damage. While still in early research stages, gene therapy holds potential for conditions where a single gene abnormality drives the disease process.

Researchers are also investigating whether medications that affect the gut microbiome (the community of bacteria living in your intestines) might help slow kidney disease. Some studies suggest that certain bacteria produce toxins that accumulate when kidneys fail, contributing to further damage. Experimental treatments that alter the gut bacteria or neutralize these toxins are being tested.

Clinical trials for kidney disease take place in medical centers across the United States, Europe, and many other countries worldwide. To participate, patients usually need to meet specific criteria related to their stage of kidney disease, age, and other health conditions. Your kidney doctor (nephrologist) can help you determine if there are clinical trials you might be eligible for. Participation in clinical trials is voluntary, and patients can withdraw at any time if they wish.

Most common treatment methods

  • Blood pressure medications
    • ACE inhibitors like ramipril, enalapril, and lisinopril help relax blood vessels and reduce strain on kidneys
    • Angiotensin-II receptor blockers (ARBs) provide similar kidney protection if ACE inhibitors cause troublesome side effects
    • These medications are especially important for patients with protein in their urine
  • Diabetes management medications
    • SGLT2 inhibitors such as dapagliflozin lower blood sugar and protect kidneys from damage
    • Finerenone blocks hormones that can harm kidney tissue
    • Insulin and metformin help control blood sugar levels to prevent further kidney damage
  • Cholesterol-lowering therapy
    • Statins like atorvastatin and simvastatin reduce cardiovascular disease risk in kidney disease patients
    • These medications help prevent heart attacks and strokes, which are common complications of kidney disease
  • Management of mineral imbalances
    • Sodium zirconium cyclosilicate treats dangerously high potassium levels
    • Phosphate binders prevent phosphorus absorption from food to protect bones and blood vessels
    • Vitamin D supplements help maintain bone health when kidneys can't activate this vitamin
  • Anemia treatment
    • Erythropoietin-stimulating medications replace the hormone kidneys normally produce to make red blood cells
    • Iron supplements support red blood cell production and reduce fatigue
  • Dialysis
    • Hemodialysis uses a machine to filter blood, typically three times per week at a dialysis center or at home
    • Peritoneal dialysis uses fluid placed in the abdomen to absorb waste, which is then drained
    • Required when kidneys reach end-stage failure and can no longer sustain life on their own
  • Kidney transplantation
    • Involves surgically placing a healthy kidney from a living or deceased donor into the patient's body
    • Requires lifelong immunosuppressant medications to prevent rejection of the transplanted kidney
    • Offers the potential for longer and more active life compared to dialysis
  • Lifestyle modifications
    • Limiting salt intake to less than 6 grams per day helps control blood pressure
    • Regular physical activity strengthens overall health and may slow disease progression
    • Stopping smoking reduces further damage to blood vessels in the kidneys
    • Managing alcohol consumption to no more than 14 units per week

Did you know?

  1. More than 1 in 7 American adults has chronic kidney disease, yet as many as 9 in 10 don't know they have it because early stages usually have no symptoms[8].
  2. Although kidney diseases are a leading cause of death in the United States, diagnostic tests influence about 70 percent of healthcare decisions yet only receive 3 to 5 percent of healthcare budgets.
  3. You can live well with only one kidney as long as it's functioning properly, and many people donate a kidney to family members or friends in need of a transplant[1].

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Renal impairment

Recruiting trials first

See all 4 trials →
Quick filters

4 clinical trials in this condition

Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Iohexol
  • Sponsor:University Of Helsinki

Renal impairment

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Gs-5245
  • Sponsor:Gilead Sciences Inc.
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Azd3427
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Iohexol
  • Sponsor:ENYO Pharma
See all 4 trials →filters applied: condition = Renal impairment

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).